Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance.

Alice MariottiniAnna Maria RepiceAlessandro BarilaroLuca Massacesi

Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2022)

Keyphrases

sars cov
public health
respiratory syndrome coronavirus
pulmonary embolism
adverse drug
drug induced